SXTC
China SXT Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$2.23
+1.36%Margins
Gross margin
44.4%
EBITDA margin
-329.8%
EBIT margin
-336.5%
Net margin
-290.7%
FCF margin
-203.0%
-24.8%
Return on equity
-21.2%
Return on assets
-27.7%
Return on invested capital
0.07x
Asset turnover
-$6.1M
Cash from operations
$53
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026